Acute Coronary Syndrome

12 competing products in clinical development for Acute Coronary Syndrome.

Pipeline by Phase

Pre-clinical1

Phase 12

Phase 24

Phase 32

Approved3

All Products (12)

Product	Company	Stage	Status	Hype
30-day DAPT + Guideline-directed therapy	Daiichi Sankyo	Approved	Recruiting	50
high-dose rosuvastatin + low-dose rosuvastatin plus ezetimibe	Yuhan	Approved	Completed	43
Modification of Prasugrel based on a biological assay + prasugrel / clopidogrel	Daiichi Sankyo	Approved	Completed	43
Prasugrel + Clopidogrel	Daiichi Sankyo	Phase 3	Completed	40
Clopidogrel + Prasugrel + Commercially-available Aspirin	Daiichi Sankyo	Phase 3	Completed	40
Prasugrel + Clopidogrel	Daiichi Sankyo	Phase 2	Completed	35
YM150 + Placebo	Astellas Pharma	Phase 2	Completed	35
E5555 + E5555 + E5555 + Placebo	Eisai	Phase 2	Completed	35
E5555 + Placebo	Eisai	Phase 2	Completed	35
YH14659 + clopidogrel & aspirin	Yuhan	Phase 1	Completed	29
YH14659 + clopidogrel & aspirin	Yuhan	Phase 1	Completed	29
ADP receptor inhibitors	Daiichi Sankyo	Pre-clinical	Completed	26